CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | 17beta-estradiol 3-benzoate |
|
Accession: | CHEBI:77006
|
browse the term
|
Definition: | A benzoate ester resulting from the formal condensation of benzoic acid with the phenolic hydroxy group of 17beta-estradiol. |
Synonyms: | exact_synonym: | (17beta)-17-hydroxyestra-1(10),2,4-trien-3-yl benzoate |
| related_synonym: | 17-beta-Estradiol 3-benzoate; 17beta-estradiol monobenzoate; Agofollin Depot; Benovocylin; Benzo-Gynoestryl; Benztrone; Estrogin; Folone; Formula=C25H28O3; InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1; InChIKey=UYIFTLBWAOGQBI-BZDYCCQFSA-N; Mesalin; Ovahormon; Ovasterol-B; Primogyn B; Progynon B; Progynon benzoate; SMILES=C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)c5ccccc5)ccc34)[C@@H]1CC[C@@H]2O; benzoate d'estradiol; benzoato de estradiol; beta-estradiol 3-benzoate; estra-1,3,5(10)-triene-3,17beta-diol 3-benzoate; estradiol benzoate; estradiol monobenzoate; estradioli benzoas; oestradiol 3-benzoate; oestradiol benzoate; oestradiol monobenzoate |
| xref: | CAS:50-50-0; DrugBank:DB00783; Drug_Central:1058; KEGG:C13444; KEGG:D01953; LINCS:LSM-26352 |
| xref_mesh: | MESH:C074283 |
| xref: | PMID:18356042; PMID:19090709; Reaxys:3107526; Wikipedia:Estradiol_benzoate |
|
|
|
G |
A2m |
alpha-2-macroglobulin |
increases methylation multiple interactions |
EXP |
estradiol 3-benzoate results in increased methylation of A2M promoter [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of A2M mRNA |
CTD |
PMID:27415467 PMID:32741896 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aadacl3 |
arylacetamide deacetylase-like 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of AADACL3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:156,242,182...156,252,215
Ensembl chr 5:156,243,415...156,252,205
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in decreased expression of ABCB1A mRNA estradiol 3-benzoate results in increased expression of ABCB1A mRNA fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of ABCB1A mRNA] |
CTD |
PMID:23707492 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
decreases expression multiple interactions |
EXP |
estradiol 3-benzoate results in decreased expression of ABCB1B mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABCB1B mRNA; Fulvestrant inhibits the reaction [estradiol 3-benzoate results in decreased expression of ABCB1B mRNA] |
CTD |
PMID:23707492 PMID:32741896 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of ABCC1 protein |
CTD |
PMID:23707492 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of ABCC2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
decreases expression increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in decreased expression of ABCC4 protein estradiol 3-benzoate results in increased expression of ABCC4 mRNA; estradiol 3-benzoate results in increased expression of ABCC4 protein fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of ABCC4 mRNA] |
CTD |
PMID:23707492 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
affects expression increases expression multiple interactions |
EXP |
estradiol 3-benzoate affects the expression of ABCC5 protein estradiol 3-benzoate results in increased expression of ABCC5 mRNA; estradiol 3-benzoate results in increased expression of ABCC5 protein [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABCC5 mRNA |
CTD |
PMID:23707492 PMID:32741896 |
|
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABCC8 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
|
|
G |
Abcc9 |
ATP binding cassette subfamily C member 9 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABCC9 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of ABCG2 mRNA; estradiol 3-benzoate results in decreased expression of ABCG2 protein |
CTD |
PMID:23707492 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abcg3l3 |
ATP-binding cassette, subfamily G (WHITE), member 3-like 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABCG3L3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:4,844,161...4,892,194
Ensembl chr14:4,844,218...4,892,194
|
|
G |
Abi3bp |
ABI family member 3 binding protein |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABI3BP mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929
|
|
G |
Acap1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:54,605,323...54,619,472
Ensembl chr10:54,605,323...54,619,472
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ACE2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Acod1 |
aconitate decarboxylase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACOD1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:79,871,819...79,881,101
Ensembl chr15:79,871,827...79,880,529
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ACOT1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Acrbp |
acrosin binding protein |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of ACRBP promoter |
CTD |
PMID:27415467 |
|
NCBI chr 4:157,851,149...157,864,211
Ensembl chr 4:157,841,841...157,864,213
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ACSL4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
estradiol 3-benzoate promotes the reaction [Thioacetamide results in increased expression of ACTA2 mRNA] |
CTD |
PMID:15716488 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Acvr2b |
activin A receptor type 2B |
decreases expression |
ISO |
estradiol 3-benzoate results in decreased expression of ACVR2B mRNA |
CTD |
PMID:14994273 |
|
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
|
|
G |
Adal |
adenosine deaminase-like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ADAL mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:108,101,857...108,119,557
Ensembl chr 3:108,101,857...108,118,516 Ensembl chr 3:108,101,857...108,118,516
|
|
G |
Adamts12 |
ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS12 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:60,032,873...60,327,629
Ensembl chr 2:60,032,873...60,327,629
|
|
G |
Adamts14 |
ADAM metallopeptidase with thrombospondin type 1 motif, 14 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS14 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:29,143,029...29,219,846
Ensembl chr20:29,144,354...29,219,866
|
|
G |
Adamts15 |
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS15 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:29,307,864...29,331,249
Ensembl chr 8:29,307,865...29,331,249
|
|
G |
Adamts2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:34,920,992...35,126,465
Ensembl chr10:34,921,049...35,123,821
|
|
G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
|
|
G |
Adamts6 |
ADAM metallopeptidase with thrombospondin type 1 motif, 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:35,421,510...35,633,298
|
|
G |
Adap2 |
ArfGAP with dual PH domains 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
|
|
G |
Adar |
adenosine deaminase, RNA-specific |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAR mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:175,138,391...175,178,280
Ensembl chr 2:175,138,403...175,178,282
|
|
G |
Adcy4 |
adenylate cyclase 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADCY4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:29,266,280...29,282,153
Ensembl chr15:29,266,287...29,282,108
|
|
G |
Adcy7 |
adenylate cyclase 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADCY7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
|
|
G |
Adgrb2 |
adhesion G protein-coupled receptor B2 |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of ADGRB2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRE1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Adgre4 |
adhesion G protein-coupled receptor E4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRE4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760
|
|
G |
Adgrg5 |
adhesion G protein-coupled receptor G5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRG5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:10,074,787...10,098,640
Ensembl chr19:10,079,375...10,097,214
|
|
G |
Adgrg7 |
adhesion G protein-coupled receptor G7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRG7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:43,808,101...43,877,539
Ensembl chr11:43,813,801...43,876,316
|
|
G |
Adm2 |
adrenomedullin 2 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of ADM2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:120,393,179...120,394,965
Ensembl chr 7:120,393,179...120,396,331
|
|
G |
Ado |
2-aminoethanethiol dioxygenase |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of ADO promoter |
CTD |
PMID:27415467 |
|
NCBI chr20:21,044,815...21,045,983
Ensembl chr20:21,044,555...21,049,235
|
|
G |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AGAP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:62,897,282...62,914,295
Ensembl chr 7:62,897,282...62,914,295
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AIF1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Aim2 |
absent in melanoma 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AIM2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:85,865,206...85,906,996
Ensembl chr13:85,866,284...85,906,975
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ALDH4A1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ALDOB mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ALOX5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ALOX5AP mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
|
|
G |
Amz1 |
archaelysin family metallopeptidase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AMZ1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:13,886,518...13,924,275
Ensembl chr12:13,891,123...13,909,783
|
|
G |
Angptl1 |
angiopoietin-like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ANGPTL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:68,963,186...68,981,649
Ensembl chr13:68,962,991...68,992,570
|
|
G |
Ankk1 |
ankyrin repeat and kinase domain containing 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANKK1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:49,779,862...49,788,024
Ensembl chr 8:49,779,862...49,788,024
|
|
G |
Ankrd66 |
ankyrin repeat domain 66 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANKRD66 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:17,421,432...17,441,212
Ensembl chr 9:17,411,983...17,442,647
|
|
G |
Anxa13 |
annexin A13 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANXA13 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
|
|
G |
Aoah |
acyloxyacyl hydrolase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AOAH mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:43,808,110...44,049,458
Ensembl chr17:43,809,638...44,049,148
|
|
G |
Ap1m2 |
adaptor related protein complex 1 subunit mu 2 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of AP1M2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 8:19,838,579...19,856,560
Ensembl chr 8:19,838,580...19,856,482
|
|
G |
Ap1s2 |
adaptor related protein complex 1 subunit sigma 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AP1S2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:30,572,746...30,598,961
Ensembl chr X:30,572,751...30,597,262
|
|
G |
Apba2 |
amyloid beta precursor protein binding family A member 2 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of APBA2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:118,053,270...118,286,858
Ensembl chr 1:118,103,219...118,285,699
|
|
G |
Apobec1 |
apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOBEC1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:155,800,030...155,828,515
Ensembl chr 4:155,800,887...155,827,390
|
|
G |
Apobr |
apolipoprotein B receptor |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOBR mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:181,169,019...181,173,206
Ensembl chr 1:181,168,916...181,173,528
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of APOC3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Apod |
apolipoprotein D |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOD mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Apol7b |
apolipoprotein L7b |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOL7B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:109,118,559...109,149,798
Ensembl chr 7:109,131,064...109,147,649
|
|
G |
Apol7b-ps1 |
apolipoprotein L7b, pseudogene 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOL7B-PS1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:109,156,746...109,175,642
|
|
G |
Apol9a |
apolipoprotein L9a |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOL9A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649
|
|
G |
Aqp2 |
aquaporin 2 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of AQP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:130,711,433...130,716,468
Ensembl chr 7:130,711,413...130,716,468
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AQP3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Ar |
androgen receptor |
multiple interactions affects expression |
EXP |
Flutamide inhibits the reaction [estradiol 3-benzoate results in increased expression of AR mRNA] estradiol 3-benzoate affects the expression of AR mRNA |
CTD |
PMID:15925091 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arf6 |
ADP-ribosylation factor 6 |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of ARF6 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 6:87,853,742...87,854,890
Ensembl chr 6:87,840,142...87,874,114
|
|
G |
Arhgap15 |
Rho GTPase activating protein 15 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP15 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:27,989,368...28,592,722
Ensembl chr 3:27,989,633...28,600,265
|
|
G |
Arhgap4 |
Rho GTPase activating protein 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:151,636,071...151,651,528
Ensembl chr X:151,632,454...151,651,128
|
|
G |
Arhgap9 |
Rho GTPase activating protein 9 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP9 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:63,148,573...63,157,025
Ensembl chr 7:63,148,900...63,157,524
|
|
G |
Arhgef2 |
Rho/Rac guanine nucleotide exchange factor 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGEF2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
|
|
G |
Arl5c |
ADP-ribosylation factor like GTPase 5C |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARL5C mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:82,985,213...82,993,425
Ensembl chr10:82,985,216...82,992,002
|
|
G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of ARNT2 mRNA; estradiol 3-benzoate results in increased expression of ARNT2 protein |
CTD |
PMID:12859947 |
|
NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:138,189,940...138,393,153
|
|
G |
As3mt |
arsenite methyltransferase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of AS3MT mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:245,596,108...245,627,872
|
|
G |
Asl |
argininosuccinate lyase |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of ASL promoter |
CTD |
PMID:27415467 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Aspg |
asparaginase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ASPG mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ASS1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atp12a |
ATPase H+/K+ transporting non-gastric alpha2 subunit |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ATP12A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
|
|
G |
Atp13a5 |
ATPase 13A5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ATP13A5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:71,376,388...71,515,789
Ensembl chr11:71,376,422...71,515,789
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of and results in increased activity of ATP1A1 protein |
CTD |
PMID:22759964 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp8a2 |
ATPase phospholipid transporting 8A2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ATP8A2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:33,817,309...34,350,193
Ensembl chr15:33,819,755...34,350,223
|
|
G |
Atp8b4 |
ATPase phospholipid transporting 8B4 (putative) |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ATP8B4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:113,554,979...113,757,635
Ensembl chr 3:113,556,192...113,757,225
|
|
G |
B430306N03Rikl |
RIKEN cDNA B430306N03 gene |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of B430306N03RIKL mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:12,681,290...12,690,555
Ensembl chr 9:12,681,535...12,690,629
|
|
G |
Baalc |
BAALC binder of MAP3K1 and KLF4 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of BAALC promoter |
CTD |
PMID:27415467 |
|
NCBI chr 7:69,918,998...69,992,289
Ensembl chr 7:69,918,998...69,992,288
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BARD1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Batf |
basic leucine zipper ATF-like transcription factor |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of BATF promoter |
CTD |
PMID:27415467 |
|
NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051
|
|
G |
Batf3 |
basic leucine zipper ATF-like transcription factor 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BATF3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:102,689,657...102,701,241
Ensembl chr13:102,689,657...102,701,139
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of BAX mRNA; estradiol 3-benzoate results in increased expression of BAX protein Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BAX mRNA]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BAX protein] |
CTD |
PMID:24316378 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression |
EXP |
Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 mRNA]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 protein] estradiol 3-benzoate results in increased expression of BCL2 mRNA; estradiol 3-benzoate results in increased expression of BCL2 protein |
CTD |
PMID:24316378 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
affects expression |
EXP |
estradiol 3-benzoate affects the expression of BCL2L1 mRNA |
CTD |
PMID:15664431 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BCL3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of BDNF mRNA |
CTD |
PMID:21277884 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Best4 |
bestrophin 4 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of BEST4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:130,622,194...130,629,045
Ensembl chr 5:130,623,438...130,627,099
|
|
G |
Bex4 |
brain expressed, X-linked 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of BEX4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:99,131,985...99,133,417
Ensembl chr X:99,131,942...99,133,531
|
|
G |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of BHLHE22 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:100,486,400...100,489,510
Ensembl chr 2:100,486,400...100,489,510
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of BID protein Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BID protein] |
CTD |
PMID:24316378 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BIRC3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Bmerb1 |
bMERB domain containing 1 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of BMERB1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:1,779,834...1,946,586
Ensembl chr10:1,779,835...1,946,575
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
decreases expression multiple interactions |
EXP |
estradiol 3-benzoate results in decreased expression of BMP7 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of BMP7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Bmper |
BMP-binding endothelial regulator |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BMPER mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:21,732,225...21,977,261
Ensembl chr 8:21,732,225...21,977,256
|
|
G |
Brinp3 |
BMP/retinoic acid inducible neural specific 3 |
increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of BRINP3 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BRINP3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:58,413,883...58,846,828
Ensembl chr13:58,413,883...58,846,770
|
|
G |
Bst1 |
bone marrow stromal cell antigen 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BST1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
|
|
G |
Btbd3 |
BTB domain containing 3 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of BTBD3 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 3:125,591,427...125,621,660
Ensembl chr 3:125,591,490...125,619,038
|
|
G |
Btg4 |
BTG anti-proliferation factor 4 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of BTG4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:51,410,774...51,425,802
Ensembl chr 8:51,422,061...51,425,796
|
|
G |
Btk |
Bruton tyrosine kinase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BTK mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
|
|
G |
Btla |
B and T lymphocyte associated |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BTLA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:55,563,683...55,588,187
Ensembl chr11:55,564,899...55,587,181
|
|
G |
Btn2a2 |
butyrophilin, subfamily 2, member A2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of BTN2A2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:41,620,807...41,632,621
Ensembl chr17:41,620,839...41,632,618
|
|
G |
Btnl9 |
butyrophilin-like 9 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BTNL9 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:33,466,059...33,489,229
Ensembl chr10:33,470,536...33,489,025
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BUB1B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
C1qa |
complement C1q A chain |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qb |
complement C1q B chain |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QB mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C1qc |
complement C1q C chain |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QC mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C1r |
complement C1r |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1R mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
|
|
G |
C1s |
complement C1s |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1S mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C1s-ps1 |
complement C1s, pseudogene 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1S-PS1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:157,059,237...157,061,211
|
|
G |
C2 |
complement C2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
|
|
G |
C3 |
complement C3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C3ar1 |
complement C3a receptor 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C3AR1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
C4a |
complement C4A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C4A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:4,005,731...4,020,083
Ensembl chr20:4,005,731...4,020,080
|
|
G |
C4b |
complement C4B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C4B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
C5ar2 |
complement C5a receptor 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C5AR2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:76,930,381...76,945,432
Ensembl chr 1:76,930,383...76,959,517
|
|
G |
C6 |
complement C6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
|
|
G |
C7 |
complement C7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
|
|
G |
Cabp4 |
calcium binding protein 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CABP4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:201,428,671...201,442,950
Ensembl chr 1:201,428,672...201,433,172
|
|
G |
Cacnb2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of CACNB2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
|
|
G |
Cacng6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CACNG6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:65,732,910...65,747,377
Ensembl chr 1:65,732,632...65,747,341
|
|
G |
Cacybp |
calcyclin binding protein |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of CACYBP promoter |
CTD |
PMID:27415467 |
|
NCBI chr13:72,437,485...72,447,810
Ensembl chr13:72,437,490...72,450,177
|
|
G |
Calhm6 |
calcium homeostasis modulator family member 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM26F mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278
|
|
G |
Camp |
cathelicidin antimicrobial peptide |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CAMP mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:109,841,729...109,843,543
Ensembl chr 8:109,841,729...109,843,543
|
|
G |
Capn8 |
calpain 8 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of CAPN8 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146
|
|
G |
Capns2 |
calpain, small subunit 2 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of CAPNS2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr19:14,104,334...14,105,276
|
|
G |
Car4 |
carbonic anhydrase 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CAR4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:69,827,945...69,836,501
Ensembl chr10:69,827,945...69,836,501
|
|
G |
Card11 |
caspase recruitment domain family, member 11 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CARD11 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
|
|
G |
Card14 |
caspase recruitment domain family, member 14 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CARD14 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:104,572,059...104,601,606
Ensembl chr10:104,566,424...104,601,905
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CASP1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CASP12 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of and results in increased activity of CASP3 protein; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of and results in increased activity of CASP3 protein] |
CTD |
PMID:24316378 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of CASP8 mRNA estradiol 3-benzoate results in increased expression of and results in increased activity of CASP8 protein; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of and results in increased activity of CASP8 protein]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of CASP8 mRNA] |
CTD |
PMID:24316378 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
EXP |
estradiol 3-benzoate results in increased expression of and results in increased activity of CASP9 protein; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of and results in increased activity of CASP9 protein]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of CASP9 mRNA] |
CTD |
PMID:24316378 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cass4 |
Cas scaffold protein family member 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CASS4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:161,162,520...161,202,523
Ensembl chr 3:161,163,436...161,202,186
|
|
G |
Cat |
catalase |
multiple interactions decreases expression |
EXP |
Quercetin inhibits the reaction [estradiol 3-benzoate results in decreased expression of CAT protein] |
CTD |
PMID:24316378 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccdc162 |
coiled-coil domain containing 162 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CCDC162 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:45,044,891...45,237,905
Ensembl chr20:45,032,752...45,236,193
|
|
G |
Ccdc170 |
coiled-coil domain containing 170 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCDC170 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:40,945,607...41,050,010
Ensembl chr 1:40,945,961...41,085,040
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCDC80 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
|
|
G |
Ccdc82 |
coiled-coil domain containing 82 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCDC82 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:10,227,727...10,265,963
Ensembl chr 8:10,228,430...10,265,963
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL11 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL12 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL19 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl28 |
C-C motif chemokine ligand 28 |
multiple interactions increases expression |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL28 mRNA estradiol 3-benzoate results in increased expression of CCL28 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCN2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn5 |
cellular communication network factor 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of WISP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCNA2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCNB1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCNB2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccr10 |
C-C motif chemokine receptor 10 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of CCR10 promoter |
CTD |
PMID:27415467 |
|
NCBI chr10:86,108,551...86,110,988
Ensembl chr10:86,108,551...86,110,988
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCR3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCR5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCR6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
|
|
G |
Ccrl2 |
C-C motif chemokine receptor like 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCRL2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
|
|
G |
Cd163 |
CD163 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD163 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd177 |
CD177 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD177 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:80,340,034...80,360,599
Ensembl chr 1:80,340,034...80,360,621
|
|
G |
Cd19 |
CD19 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD19 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975
|
|
G |
Cd200r1 |
CD200 receptor 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD200R1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:55,886,937...55,921,217
Ensembl chr11:55,887,717...55,921,285
|
|
G |
Cd22 |
CD22 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD22 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
|
|
G |
Cd226 |
CD226 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD226 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:82,449,924...82,545,107
Ensembl chr18:82,450,568...82,543,051
|
|
G |
Cd274 |
CD274 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD274 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cd300a |
Cd300a molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:99,929,801...99,942,674
Ensembl chr10:99,929,801...99,942,674
|
|
G |
Cd300c2 |
CD300C molecule 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300C2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:100,253,312...100,258,553
Ensembl chr10:100,253,624...100,258,323
|
|
G |
Cd300ld |
Cd300 molecule-like family member D |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300LD mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:100,082,957...100,115,853
Ensembl chr10:100,083,490...100,115,821
|
|
G |
Cd300le |
Cd300 molecule-like family member E |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300LE mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:100,271,076...100,280,400
Ensembl chr10:100,271,036...100,280,299
|
|
G |
Cd300lf |
Cd300 molecule-like family member F |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300LF mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:100,359,942...100,376,130
Ensembl chr10:100,359,943...100,376,041
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD36 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd3e |
CD3 epsilon subunit of T-cell receptor complex |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD3E mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:45,303,848...45,315,005
Ensembl chr 8:45,303,852...45,315,022
|
|
G |
Cd4 |
Cd4 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:157,668,878...157,695,366
|
|
G |
Cd48 |
Cd48 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD48 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
|
|
G |
Cd5 |
Cd5 molecule |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of CD5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313
|
|
G |
Cd52 |
CD52 molecule |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of CD52 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
|
|
G |
Cd53 |
Cd53 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD53 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:194,352,139...194,399,668
Ensembl chr 2:194,352,139...194,399,657
|
|
G |
Cd5l |
Cd5 molecule-like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD5L mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
|
|
G |
Cd68 |
Cd68 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD68 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cd72 |
Cd72 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD72 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:57,697,361...57,704,980
Ensembl chr 5:57,697,367...57,704,725
|
|
G |
Cd74 |
CD74 molecule |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD74 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cdca3 |
cell division cycle associated 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CDCA3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdh15 |
cadherin 15 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CDH15 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:50,903,757...50,927,151
Ensembl chr19:50,903,638...50,927,105
|
|
G |
Cdh7 |
cadherin 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CDH7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:26,672,058...26,821,571
Ensembl chr13:26,672,484...26,819,846
|
|
G |
Cdkl4 |
cyclin-dependent kinase-like 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CDKL4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:14,449,822...14,492,568
Ensembl chr 6:14,450,681...14,492,046
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CDS1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
|
|
G |
Ceacam19 |
CEA cell adhesion molecule 19 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CEACAM19 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:79,542,107...79,550,927
Ensembl chr 1:79,542,107...79,550,927
|
|
G |
Cebpe |
CCAAT/enhancer binding protein epsilon |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CEBPE mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CELF2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
|
|
G |
Celf4 |
CUGBP, Elav-like family member 4 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of CELF4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:16,786,578...17,065,045
Ensembl chr18:16,786,867...17,064,786
|
|
G |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CELSR1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:116,987,616...117,125,035
Ensembl chr 7:116,987,605...117,125,164
|
|
G |
Cenpa |
centromere protein A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CENPA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpf |
centromere protein F |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CENPF mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cenpt |
centromere protein T |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CENPT mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:33,734,684...33,741,159
Ensembl chr19:33,734,685...33,741,142
|
|
G |
Cenpw |
centromere protein W |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CENPW mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
|
|
G |
Cfap210 |
cilia and flagella associated protein 210 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CFAP210 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:54,520,455...54,554,677
Ensembl chr 3:54,520,458...54,554,607
|
|
G |
Cfb |
complement factor B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CFB mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cfc1 |
cripto, FRL-1, cryptic family 1 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of CFC1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:36,742,106...36,751,931
Ensembl chr 9:36,739,071...36,751,930
|
|
G |
Cfi |
complement factor I |
increases methylation multiple interactions |
EXP |
estradiol 3-benzoate results in increased methylation of CFI promoter [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CFI mRNA |
CTD |
PMID:27415467 PMID:32741896 |
|
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
|
|
G |
Cfp |
complement factor properdin |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CFP mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
decreases expression |
ISO |
estradiol 3-benzoate results in decreased expression of CGA mRNA |
CTD |
PMID:15223135 |
|
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
|
|
G |
Chad |
chondroadherin |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of CHAD promoter |
CTD |
PMID:27415467 |
|
NCBI chr10:79,512,170...79,515,941
Ensembl chr10:79,511,931...79,515,940
|
|
G |
Chgb |
chromogranin B |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of CHGB mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CHI3L1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
|
|
G |
Chmp4bl1 |
chromatin modifying protein 4B-like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CHMP4BL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:68,049,742...68,050,791
Ensembl chr 4:68,049,705...68,050,676
|
|
G |
Chp2 |
calcineurin-like EF hand protein 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CHP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:176,757,945...176,772,443
Ensembl chr 1:176,757,876...176,772,139
|
|
G |
Chrd |
chordin |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CHRD mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:80,171,994...80,181,166
Ensembl chr11:80,171,994...80,180,673
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of CHRNA3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CHRNB4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Chst14 |
carbohydrate sulfotransferase 14 |
decreases methylation increases expression |
EXP |
estradiol 3-benzoate results in decreased methylation of CHST14 promoter estradiol 3-benzoate results in increased expression of CHST14 mRNA |
CTD |
PMID:27415467 |
|
NCBI chr 3:105,916,481...105,918,538
Ensembl chr 3:105,916,466...105,918,548
|
|
G |
Ciita |
class II, major histocompatibility complex, transactivator |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CIITA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKAP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
|
|
G |
Ckap2l |
cytoskeleton associated protein 2-like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKAP2L mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
|
|
G |
Ckmt1 |
creatine kinase, mitochondrial 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKMT1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:108,329,859...108,335,760
Ensembl chr 3:108,330,705...108,335,758
|
|
G |
Clca1 |
chloride channel accessory 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
|
|
G |
Clca2 |
chloride channel accessory 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:233,993,619...234,022,691
Ensembl chr 2:233,995,078...234,022,199
|
|
G |
Clca4l |
chloride channel calcium activated 4-like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA4L mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:233,826,133...233,846,137
Ensembl chr 2:233,826,133...233,846,716
|
|
G |
Clca5 |
chloride channel accessory 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:233,796,569...233,818,867
Ensembl chr 2:233,796,575...233,818,949
|
|
G |
Clcnkb |
chloride voltage-gated channel Kb |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CLCNKB mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:153,710,086...153,733,162
Ensembl chr 5:153,710,094...153,732,153
|
|
G |
Cldn10 |
claudin 10 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of CLDN10 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:95,862,785...95,954,526
Ensembl chr15:95,862,760...95,954,526
|
|
G |
Clec10a |
C-type lectin domain containing 10A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC10A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:54,876,244...54,880,439
Ensembl chr10:54,876,260...54,880,435
|
|
G |
Clec12a |
C-type lectin domain family 12, member A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC12A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
|
|
G |
Clec4a1 |
C-type lectin domain family 4, member A1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4A1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008
|
|
G |
Clec4a3 |
C-type lectin domain family 4, member A3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4A mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4A3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:156,214,030...156,224,818
Ensembl chr 4:156,214,718...156,224,817
|
|
G |
Clec4d |
C-type lectin domain family 4, member D |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4D mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848
|
|
G |
Clec4e |
C-type lectin domain family 4, member E |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4E mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:156,606,927...156,612,911
Ensembl chr 4:156,607,614...156,612,767
|
|
G |
Clec7a |
C-type lectin domain containing 7A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC7A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
|
|
G |
Clec9a |
C-type lectin domain containing 9A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC9A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:162,859,742...162,875,742
Ensembl chr 4:162,860,308...162,875,352
|
|
G |
Clspn |
claspin |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLSPN mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
|
|
G |
Cltrn |
collectrin, amino acid transport regulator |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of CLTRN promoter |
CTD |
PMID:27415467 |
|
NCBI chr X:30,361,967...30,395,264
Ensembl chr X:30,361,967...30,395,349
|
|
G |
Clu |
clusterin |
affects expression |
EXP |
estradiol 3-benzoate affects the expression of CLU mRNA |
CTD |
PMID:15925091 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Clxn |
calaxin |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLXN mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:85,977,231...85,996,561
Ensembl chr11:85,983,304...85,996,538
|
|
G |
Cmbl |
carboxymethylenebutenolidase homolog |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CMBL mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
|
|
G |
Cmklr1 |
chemerin chemokine-like receptor 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CMKLR1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:42,974,462...43,027,321
Ensembl chr12:42,974,410...43,028,129
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of CMPK2 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CMPK2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
|
|
G |
Cmtm3 |
CKLF-like MARVEL transmembrane domain containing 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CMTM3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:622,563...630,721
Ensembl chr19:604,458...629,790
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CNDP1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
|
|
G |
Cnga1 |
cyclic nucleotide gated channel subunit alpha 1 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of CNGA1 protein |
CTD |
PMID:22759964 |
|
NCBI chr14:35,566,947...35,605,065
Ensembl chr14:35,567,125...35,605,065
|
|
G |
Cnn2 |
calponin 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CNN2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:9,712,505...9,719,678
Ensembl chr 7:9,712,516...9,719,656
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CNR2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
|
|
G |
Cntnap1 |
contactin associated protein 1 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of CNTNAP1 promoter |
CTD |
PMID:27415467 |
|
NCBI chr10:86,109,850...86,125,612
Ensembl chr10:86,111,643...86,125,611
|
|
G |
Coasy |
Coenzyme A synthase |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of COASY promoter |
CTD |
PMID:27415467 |
|
NCBI chr10:86,014,566...86,018,849
Ensembl chr10:86,014,597...86,018,841
|
|
G |
Col15a1 |
collagen type XV alpha 1 chain |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL15A1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL3A1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL5A1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL6A2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
|
|
G |
Colec12 |
collectin sub-family member 12 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COLEC12 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
|
|
G |
Corin |
corin, serine peptidase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CORIN mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:35,680,601...35,910,703
Ensembl chr14:35,681,304...35,909,503
|
|
G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CPEB3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
|
|
G |
Cpne7 |
copine 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CPNE7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:51,164,316...51,182,676
Ensembl chr19:51,166,034...51,182,677
|
|
G |
Cpz |
carboxypeptidase Z |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CPZ mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:75,223,692...75,246,946
Ensembl chr14:75,223,605...75,246,945
|
|
G |
Creb3l4 |
cAMP responsive element binding protein 3-like 4 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of CREB3L4 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932
|
|
G |
Creb5 |
cAMP responsive element binding protein 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CREB5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:82,393,091...82,794,320
Ensembl chr 4:82,393,730...82,790,325
|
|
G |
Crh |
corticotropin releasing hormone |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of CRH mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Crmp1 |
collapsin response mediator protein 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CRMP1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:73,509,933...73,556,192
Ensembl chr14:73,509,933...73,556,177
|
|
G |
Crym |
crystallin, mu |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CRYM mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSF1R mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf3r |
colony stimulating factor 3 receptor |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSF3R mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
|
|
G |
Csgalnact1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSGALNACT1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr16:20,995,210...21,330,586
Ensembl chr16:21,235,784...21,330,319
|
|
G |
Cst7 |
cystatin F |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CST7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557
|
|
G |
Csta |
cystatin A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSTA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
|
|
G |
Cth |
cystathionine gamma-lyase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CTH mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctrc |
chymotrypsin C |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CTRC mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:154,147,314...154,156,540
Ensembl chr 5:154,147,316...154,156,528
|
|
G |
Ctss |
cathepsin S |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CTSS mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Ctsw |
cathepsin W |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CTSW mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:202,772,395...202,777,021
Ensembl chr 1:202,772,572...202,775,964
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL13 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL9 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of CXCR2 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCR2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCR4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cxcr6 |
C-X-C motif chemokine receptor 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCR6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:123,434,417...123,439,568
Ensembl chr 8:123,416,325...123,439,526
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYBA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYBB mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cygb |
cytoglobin |
multiple interactions |
EXP |
estradiol 3-benzoate promotes the reaction [Thioacetamide results in increased expression of CYGB mRNA] |
CTD |
PMID:15716488 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of CYP17A1 protein |
CTD |
PMID:24752506 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
affects response to substance |
ISO |
CYP19A1 protein affects the susceptibility to estradiol 3-benzoate |
CTD |
PMID:16884724 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases expression multiple interactions |
EXP |
estradiol 3-benzoate results in decreased expression of CYP1B1 protein [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYP1B1 mRNA |
CTD |
PMID:24752506 PMID:32741896 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CYP26A1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of CYP2A1 protein |
CTD |
PMID:24752506 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CYP2C13 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:238,786,764...238,867,195
Ensembl chr 1:238,786,765...238,867,191
|
|
G |
Cyp2c22 |
cytochrome P450, family 2, subfamily c, polypeptide 22 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of CYP2C22 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:238,991,698...239,031,323
Ensembl chr 1:238,991,610...239,021,738
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYP3A9 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyth4 |
cytohesin 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYTH4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:110,152,232...110,176,726
Ensembl chr 7:110,152,272...110,176,741
|
|
G |
Dcaf12l1 |
DDB1 and CUL4 associated factor 12-like 1 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of DCAF12L1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:123,695,286...123,698,905
Ensembl chr X:123,695,286...123,698,905
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DCLK1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
|
|
G |
Ddah2 |
DDAH family member 2, ADMA-independent |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of DDAH2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
|
|
G |
Ddx60 |
DEXD/H-box helicase 60 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DDX60 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
|
|
G |
Defa5 |
defensin alpha 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEFA5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr16:70,342,530...70,344,854
Ensembl chr16:70,342,530...70,344,836
|
|
G |
Degs2 |
delta(4)-desaturase, sphingolipid 2 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of DEGS2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:127,596,063...127,613,293
Ensembl chr 6:127,596,071...127,613,293
|
|
G |
Depdc1 |
DEP domain containing 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEPDC1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
|
|
G |
Depdc1b |
DEP domain containing 1B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEPDC1B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
|
|
G |
Derl3 |
derlin 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of DERL3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
|
|
G |
Deup1 |
deuterosome assembly protein 1 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of DEUP1 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 8:12,380,300...12,442,649
Ensembl chr 8:12,380,302...12,442,199
|
|
G |
Dhrs2 |
dehydrogenase/reductase 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of DHRS2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DHX58 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
|
|
G |
Diaph3 |
diaphanous-related formin 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DIAPH3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975
|
|
G |
Dlx4 |
distal-less homeobox 4 |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of DLX4 promoter |
CTD |
PMID:27415467 |
|
NCBI chr10:80,085,037...80,090,434
Ensembl chr10:80,085,465...80,090,456
|
|
G |
Dmbt1 |
deleted in malignant brain tumors 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DMBT1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
|
|
G |
Dnase2b |
deoxyribonuclease 2 beta |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of DNASE2B promoter |
CTD |
PMID:27415467 |
|
NCBI chr 2:235,470,915...235,515,211
Ensembl chr 2:235,470,919...235,486,295
|
|
G |
Dnttip1 |
deoxynucleotidyltransferase, terminal, interacting protein 1 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of DNTTIP1 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 3:153,481,718...153,505,403
Ensembl chr 3:153,481,705...153,505,759
|
|
G |
Dock11 |
dedicator of cytokinesis 11 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOCK11 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:115,131,720...115,314,854
Ensembl chr X:115,131,909...115,314,854
|
|
G |
Dock2 |
dedicator of cytokinesis 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOCK2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:18,827,237...19,244,832
Ensembl chr10:18,827,239...19,244,808
|
|
G |
Dock4 |
dedicator of cytokinesis 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOCK4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
|
|
G |
Dok2 |
docking protein 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOK2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:45,826,984...45,841,409
Ensembl chr15:45,827,398...45,841,402
|
|
G |
Dok3 |
docking protein 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOK3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188
|
|
G |
Dpep2 |
dipeptidase 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DPEP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:33,883,557...33,896,487
Ensembl chr19:33,885,478...33,891,954
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DPP4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Drd2 |
dopamine receptor D2 |
multiple interactions |
EXP |
estradiol 3-benzoate inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] |
CTD |
PMID:10936494 |
|
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Dsc1 |
desmocollin 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of DSC1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
|
|
G |
Dsc2 |
desmocollin 2 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of DSC2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dsc3 |
desmocollin 3 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of DSC3 promoter |
CTD |
PMID:27415467 |
|
NCBI chr18:11,379,759...11,413,797
Ensembl chr18:11,377,347...11,413,797
|
|
G |
Dtx4 |
deltex E3 ubiquitin ligase 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DTX4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818
|
|
G |
Duox1 |
dual oxidase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DUOX1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
|
|
G |
Duox2 |
dual oxidase 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DUOX2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
|
|
G |
Duoxa1 |
dual oxidase maturation factor 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DUOXA1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:109,249,815...109,260,511
Ensembl chr 3:109,249,923...109,260,499
|
|
G |
Duoxa2 |
dual oxidase maturation factor 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DUOXA2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:109,245,337...109,249,055
Ensembl chr 3:109,245,476...109,248,968
|
|
G |
Dusp18 |
dual specificity phosphatase 18 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DUSP18 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:78,790,183...78,811,576
Ensembl chr14:78,787,505...78,811,576
|
|
G |
E2f7 |
E2F transcription factor 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of E2F7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
|
|
G |
E2f8 |
E2F transcription factor 8 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of E2F8 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Ebf1 |
EBF transcription factor 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBF1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
|
|
G |
Ebf3 |
EBF transcription factor 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBF3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:191,996,726...192,114,593
Ensembl chr 1:191,996,730...192,114,359
|
|
G |
Ebi3 |
Epstein-Barr virus induced 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBI3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:774,252...787,544
Ensembl chr 9:783,617...787,544
|
|
G |
Ect2 |
epithelial cell transforming 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ECT2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Efcab12 |
EF-hand calcium binding domain 12 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of EFCAB12 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:148,869,381...148,892,922
Ensembl chr 4:148,869,387...148,890,560
|
|
G |
Efnb2 |
ephrin B2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EFNB2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egf |
epidermal growth factor |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of EGF mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of EGFR protein |
CTD |
PMID:15778002 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr2 |
early growth response 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EGR2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of EHHADH mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Eif4e3 |
eukaryotic translation initiation factor 4E family member 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EIF4E3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:132,258,502...132,301,808
Ensembl chr 4:132,258,502...132,301,808
|
|
G |
Elapor2 |
endosome-lysosome associated apoptosis and autophagy regulator family member 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELAPOR2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:24,613,163...24,805,729
Ensembl chr 4:24,613,163...24,805,729
|
|
G |
Elavl2 |
ELAV like RNA binding protein 2 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of ELAVL2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097
|
|
G |
Elf5 |
E74 like ETS transcription factor 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELF5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:89,808,837...89,836,977
Ensembl chr 3:89,797,880...89,836,973
|
|
G |
Elmod1 |
ELMO domain containing 1 |
decreases expression multiple interactions |
EXP |
estradiol 3-benzoate results in decreased expression of ELMOD1 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELMOD1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:54,298,363...54,355,348
Ensembl chr 8:54,298,363...54,355,140
|
|
G |
Entpd3 |
ectonucleoside triphosphate diphosphohydrolase 3 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of ENTPD3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:120,246,412...120,277,943
Ensembl chr 8:120,247,121...120,277,943
|
|
G |
Entpd8 |
ectonucleoside triphosphate diphosphohydrolase 8 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ENTPD8 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:7,885,277...7,895,517
Ensembl chr 3:7,889,909...7,895,296
|
|
G |
Eomes |
eomesodermin |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EOMES mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316
|
|
G |
Epha5 |
EPH receptor A5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EPHA5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:23,653,393...24,020,129
Ensembl chr14:23,653,393...24,017,317
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of EPHX1 protein |
CTD |
PMID:24752506 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Epsti1 |
epithelial stromal interaction 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EPSTI1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191
|
|
G |
Erich5 |
glutamate-rich 5 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of ERICH5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:65,655,829...65,682,221
Ensembl chr 7:65,657,204...65,680,207
|
|
G |
Erp27 |
endoplasmic reticulum protein 27 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ERP27 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:169,804,656...169,821,660
Ensembl chr 4:169,804,658...169,821,660
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding affects expression increases methylation decreases expression increases expression multiple interactions |
ISO EXP |
estradiol 3-benzoate binds to ESR1 protein estradiol 3-benzoate affects the expression of ESR1 mRNA estradiol 3-benzoate results in increased methylation of ESR1 exon; estradiol 3-benzoate results in increased methylation of ESR1 intron estradiol 3-benzoate results in decreased expression of ESR1; estradiol 3-benzoate results in decreased expression of ESR1 protein estradiol 3-benzoate results in increased expression of ESR1 mRNA; estradiol 3-benzoate results in increased expression of ESR1 protein methyl palmitate inhibits the reaction [estradiol 3-benzoate results in increased expression of ESR1 protein] |
CTD |
PMID:11162928 PMID:15375486 PMID:15716488 PMID:15778002 PMID:15925091 PMID:19350480 PMID:22016562 PMID:27830003 PMID:32967526 More...
|
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
affects expression decreases expression increases expression |
EXP |
estradiol 3-benzoate affects the expression of ESR2 mRNA estradiol 3-benzoate results in decreased expression of ESR2; estradiol 3-benzoate results in decreased expression of ESR2 mRNA estradiol 3-benzoate results in increased expression of ESR2 mRNA |
CTD |
PMID:15375486 PMID:19350480 PMID:24352099 PMID:27830003 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Evi2a |
ecotropic viral integration site 2A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EVI2A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:64,485,760...64,489,660
Ensembl chr10:64,485,200...64,489,843
|
|
G |
Evi2b |
ecotropic viral integration site 2B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EVI2B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:64,472,693...64,474,311
Ensembl chr10:64,471,505...64,481,560
|
|
G |
Exoc3l4 |
exocyst complex component 3-like 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EXOC3L4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:130,452,680...130,466,684
Ensembl chr 6:130,452,661...130,466,683
|
|
G |
F10 |
coagulation factor X |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of F10 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
|
|
G |
F11r |
F11 receptor |
multiple interactions increases expression |
ISO |
fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of F11R mRNA]; fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of F11R protein] estradiol 3-benzoate results in increased expression of F11R mRNA; estradiol 3-benzoate results in increased expression of F11R protein |
CTD |
PMID:19433574 |
|
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of FAIM2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
|
|
G |
Fam163b |
family with sequence similarity 163, member B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM163B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:10,437,383...10,466,458
Ensembl chr 3:10,437,383...10,466,458
|
|
G |
Fam171b |
family with sequence similarity 171, member B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM171B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:68,930,755...68,986,113
Ensembl chr 3:68,930,822...68,986,127
|
|
G |
Fam229b |
family with sequence similarity 229, member B |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of FAM229B promoter |
CTD |
PMID:27415467 |
|
NCBI chr20:42,538,853...42,552,355
Ensembl chr20:42,538,868...42,552,248
|
|
G |
Fam3b |
FAM3 metabolism regulating signaling molecule B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM3B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:36,831,532...36,863,902
Ensembl chr11:36,831,532...36,869,713
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FAM83D mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM89A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:52,710,002...52,722,630
Ensembl chr19:52,710,019...52,722,631
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of FAS mRNA; estradiol 3-benzoate results in increased expression of FAS protein Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FAS mRNA]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FAS protein] |
CTD |
PMID:24316378 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of FASLG mRNA; estradiol 3-benzoate results in increased expression of FASLG protein Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FASLG mRNA]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FASLG protein] |
CTD |
PMID:24316378 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fbln1 |
fibulin 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FBLN1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbxo16 |
F-box protein 16 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FBXO16 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:39,492,268...39,541,493
Ensembl chr15:39,492,377...39,541,480
|
|
G |
Fbxo6 |
F-box protein 6 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of FBXO6 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 5:158,576,729...158,582,520
Ensembl chr 5:158,576,759...158,582,525
|
|
G |
Fcer1g |
Fc epsilon receptor Ig |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCER1G mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443
|
|
G |
Fcer2 |
Fc epsilon receptor II |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCER2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:1,742,809...1,754,476
Ensembl chr12:1,742,815...1,754,476
|
|
G |
Fcgbpl1 |
Fc fragment of IgG binding protein-like 1 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of FCGBPL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:83,424,788...83,462,802
Ensembl chr 1:83,424,788...83,462,799
|
|
G |
Fcgr1a |
Fc gamma receptor 1A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCGR1A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCGR2A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
|
|
G |
Fcgr2b |
Fc gamma receptor 2B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCGR2B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
|
|
G |
Fcnb |
ficolin B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCNB mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151
|
|
G |
Fcrl2 |
Fc receptor-like 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCRL2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:172,694,308...172,707,261
Ensembl chr 2:172,694,308...172,707,051
|
|
G |
Fcrl5 |
Fc receptor-like 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCRL5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:172,881,763...172,912,912
Ensembl chr 2:172,881,448...172,913,148
|
|
G |
Fermt3 |
FERM domain containing kindlin 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FERMT3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:204,189,483...204,207,683
Ensembl chr 1:204,189,484...204,207,587
|
|
G |
Ffar4 |
free fatty acid receptor 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FFAR4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:235,873,576...235,891,597
Ensembl chr 1:235,873,576...235,891,597
|
|
G |
Fgd2 |
FYVE, RhoGEF and PH domain containing 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FGD2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:7,424,795...7,441,603
Ensembl chr20:7,424,790...7,441,603
|
|
G |
Fgg |
fibrinogen gamma chain |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FGG mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FLRT2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:114,777,547...114,872,688
Ensembl chr 6:114,777,599...114,872,785
|
|
G |
Flt3 |
Fms related receptor tyrosine kinase 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FLT3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FN1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fndc1 |
fibronectin type III domain containing 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FNDC1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:47,281,839...47,364,247
Ensembl chr 1:47,281,844...47,364,259
|
|
G |
Fndc5 |
fibronectin type III domain containing 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FNDC5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:141,481,593...141,491,257
Ensembl chr 5:141,481,590...141,490,731
|
|
G |
Fndc9 |
fibronectin type III domain containing 9 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FNDC9 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:30,664,435...30,668,213
Ensembl chr10:30,667,091...30,667,771
|
|
G |
Folr2 |
folate receptor beta |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FOLR2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:156,200,044...156,218,380
Ensembl chr 1:156,200,060...156,205,724
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression multiple interactions |
EXP ISO |
estradiol 3-benzoate results in decreased expression of FOS protein [estradiol 3-benzoate co-treated with Progesterone] results in increased abundance of FOS protein |
CTD |
PMID:21190954 PMID:22577852 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FOSL2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Foxq1 |
forkhead box Q1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FOXQ1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377 Ensembl chr17:32,912,744...32,915,377
|
|
G |
Fsbp |
fibrinogen silencer binding protein |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FSBP mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:25,058,003...25,064,276
Ensembl chr 5:25,032,066...25,104,616
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FSCN1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
decreases expression multiple interactions decreases secretion |
ISO EXP |
estradiol 3-benzoate results in decreased expression of FSHB mRNA Quercetin inhibits the reaction [estradiol 3-benzoate results in decreased secretion of FSHB protein] |
CTD |
PMID:15223135 PMID:24316378 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fxyd3 |
FXYD domain-containing ion transport regulator 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FXYD3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:86,305,531...86,312,455
|
|
G |
Fyb1 |
FYN binding protein 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FYB1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:55,621,585...55,781,206
Ensembl chr 2:55,632,698...55,779,629
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FYN mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
G0s2 |
G0/G1switch 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of G0S2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
Gabbr1 |
gamma-aminobutyric acid type B receptor subunit 1 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of GABBR1 mRNA |
CTD |
PMID:21277884 |
|
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
|
|
G |
Gabra1 |
gamma-aminobutyric acid type A receptor subunit alpha 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GABRA1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
|
|
G |
Gabra4 |
gamma-aminobutyric acid type A receptor subunit alpha 4 |
multiple interactions |
EXP |
[Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of GABRA4 mRNA |
CTD |
PMID:19394921 |
|
NCBI chr14:36,590,782...36,667,724
Ensembl chr14:36,590,782...36,665,844
|
|
G |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of GALNT13 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:38,903,695...39,560,683
Ensembl chr 3:38,974,490...39,558,803
|
|
G |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GALNT14 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:21,756,039...21,977,533
Ensembl chr 6:21,755,195...21,972,192
|
|
G |
Galr3 |
galanin receptor 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GALR3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:110,603,525...110,608,429
Ensembl chr 7:110,605,226...110,607,685
|
|
G |
Gas7 |
growth arrest specific 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GAS7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:52,152,718...52,383,283
Ensembl chr10:52,152,493...52,383,276
|
|
G |
Gask1a |
golgi associated kinase 1A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM198A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:121,610,779...121,643,742
Ensembl chr 8:121,610,787...121,642,942
|
|
G |
Gbp1 |
guanylate binding protein 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gbp4 |
guanylate binding protein 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
|
|
G |
Gbp6 |
guanylate binding protein family member 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GCH1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
|
|
G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GCNT1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:214,718,293...214,758,776
|
|
G |
Gcsam |
germinal center-associated, signaling and motility |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GCSAM mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:55,195,757...55,207,011
Ensembl chr11:55,196,712...55,206,992
|
|
G |
Gda |
guanine deaminase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GDA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
|
|
G |
Gfi1 |
growth factor independent 1 transcriptional repressor |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GFI1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:2,040,576...2,056,874
Ensembl chr14:2,042,434...2,051,814
|
|
G |
Gimap6 |
GTPase, IMAP family member 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GIMAP6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:77,653,703...77,659,112
Ensembl chr 4:77,652,610...77,659,116
|
|
G |
Gimap7 |
GTPase, IMAP family member 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GIMAP7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:77,670,522...77,674,692
Ensembl chr 4:77,670,367...77,675,272
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GJB2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gjb6 |
gap junction protein, beta 6 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of GJB6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:31,284,561...31,294,552
Ensembl chr15:31,284,419...31,294,582
|
|
G |
Gk5 |
glycerol kinase 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GK5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:96,682,469...96,751,407
Ensembl chr 8:96,682,470...96,749,166
|
|
G |
Glb1l3 |
galactosidase, beta 1-like 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GLB1L3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:25,179,165...25,220,904
Ensembl chr 8:25,179,165...25,220,904
|
|
G |
Gli2 |
GLI family zinc finger 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLI2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLIPR1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
|
|
G |
Glrx |
glutaredoxin |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLRX mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glt1d1 |
glycosyltransferase 1 domain containing 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GLT1D1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:28,975,984...29,049,707
Ensembl chr12:28,975,988...29,049,695
|
|
G |
Gmfg |
glia maturation factor, gamma |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GMFG mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:83,728,797...83,739,189
Ensembl chr 1:83,728,776...83,739,183
|
|
G |
Gna15 |
G protein subunit alpha 15 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GNA15 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508
|
|
G |
Gnat2 |
G protein subunit alpha transducin 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GNAT2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:195,726,371...195,735,866
Ensembl chr 2:195,726,762...195,735,866
|
|
G |
Gngt2 |
G protein subunit gamma transducin 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GNGT2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:80,776,003...80,784,235
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with GNRH1 protein] results in increased secretion of LH protein |
CTD |
PMID:19574278 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gnrhr |
gonadotropin releasing hormone receptor |
decreases expression |
ISO |
estradiol 3-benzoate results in decreased expression of GNRHR mRNA |
CTD |
PMID:15223135 |
|
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
|
|
G |
Gp2 |
glycoprotein 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:173,797,057...173,812,619
Ensembl chr 1:173,797,057...173,812,619
|
|
G |
Gp6 |
glycoprotein VI |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GP6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:69,429,232...69,492,709
Ensembl chr 1:69,465,789...69,491,326
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPAT3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gpc5 |
glypican 5 |
multiple interactions decreases expression |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GPC5 mRNA estradiol 3-benzoate results in decreased expression of GPC5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282
|
|
G |
Gpr176 |
G protein-coupled receptor 176 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR176 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:105,236,794...105,337,664
Ensembl chr 3:105,236,795...105,337,226
|
|
G |
Gpr31 |
G protein-coupled receptor 31 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR31 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:52,926,953...52,927,912
|
|
G |
Gpr34 |
G protein-coupled receptor 34 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR34 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:9,104,829...9,113,796
Ensembl chr X:9,104,565...9,148,601
|
|
G |
Gpr35 |
G protein-coupled receptor 35 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR35 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:93,527,165...93,539,573
Ensembl chr 9:93,527,127...93,539,299
|
|
G |
Gpr68 |
G protein-coupled receptor 68 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR68 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:120,135,620...120,166,089
Ensembl chr 6:120,135,436...120,166,089
|
|
G |
Gpr84 |
G protein-coupled receptor 84 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR84 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:134,443,904...134,446,173
Ensembl chr 7:134,443,936...134,446,178
|
|
G |
Gpr87 |
G protein-coupled receptor 87 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR87 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
|
|
G |
Gprc5a |
G protein-coupled receptor, class C, group 5, member A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPRC5A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions decreases expression |
EXP |
Quercetin inhibits the reaction [estradiol 3-benzoate results in decreased expression of GPX1 mRNA] |
CTD |
PMID:24316378 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPX2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of GPX7 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
|
|
G |
Grap |
GRB2-related adaptor protein |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GRAP mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:46,298,965...46,352,057
Ensembl chr10:46,332,909...46,352,056
|
|
G |
Greb1 |
growth regulating estrogen receptor binding 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GREB1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
increases phosphorylation multiple interactions |
EXP |
estradiol 3-benzoate results in increased phosphorylation of GRIN1 protein fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased phosphorylation of GRIN1 protein]; U 0126 inhibits the reaction [estradiol 3-benzoate results in increased phosphorylation of GRIN1 protein] |
CTD |
PMID:21763338 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
increases expression decreases expression multiple interactions increases phosphorylation |
EXP |
estradiol 3-benzoate results in increased expression of GRIN2B mRNA estradiol 3-benzoate results in decreased expression of GRIN2B mRNA fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased phosphorylation of GRIN2B protein]; U 0126 inhibits the reaction [estradiol 3-benzoate results in increased phosphorylation of GRIN2B protein] |
CTD |
PMID:21190954 PMID:21277884 PMID:21763338 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Grin2c |
glutamate ionotropic receptor NMDA type subunit 2C |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of GRIN2C mRNA |
CTD |
PMID:21277884 |
|
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
|
|
G |
Grk3 |
G protein-coupled receptor kinase 3 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of GRK3 promoter |
CTD |
PMID:27415467 |
|
NCBI chr12:43,624,778...43,735,375
Ensembl chr12:43,624,897...43,731,262
|
|
G |
Grn |
granulin precursor |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of GRN mRNA |
CTD |
PMID:11137762 |
|
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Gsap |
gamma-secretase activating protein |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GSAP mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:13,813,046...13,907,875
Ensembl chr 4:13,813,046...13,907,814
|
|
G |
Gsc |
goosecoid homeobox |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GSC mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:123,388,072...123,390,111
Ensembl chr 6:123,388,072...123,390,111
|
|
G |
Gsta3l1 |
glutathione S-transferase alpha 3 like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GSTA3L1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:23,619,691...23,628,517
Ensembl chr 9:23,620,010...23,632,333
|
|
G |
Gucy2c |
guanylate cyclase 2C |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of GUCY2C promoter |
CTD |
PMID:27415467 |
|
NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092
|
|
G |
Gxylt2 |
glucoside xylosyltransferase 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GXYLT2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:133,347,230...133,449,708
Ensembl chr 4:133,347,499...133,449,454
|
|
G |
Gzmb |
granzyme B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GZMB mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
|
|
G |
Gzmm |
granzyme M |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GZMM mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:10,011,065...10,016,841
Ensembl chr 7:10,011,066...10,016,665
|
|
G |
Habp2 |
hyaluronan binding protein 2 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of HABP2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 1:255,315,870...255,350,161
Ensembl chr 1:255,315,915...255,350,160
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of HAVCR1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HCK mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
|
|
G |
Hcst |
hematopoietic cell signal transducer |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HCST mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:85,676,976...85,679,083
Ensembl chr 1:85,676,979...85,679,012
|
|
G |
Hdac9 |
histone deacetylase 9 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HDAC9 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
|
|
G |
Helz2 |
helicase with zinc finger 2 |
multiple interactions increases expression |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HELZ2 mRNA estradiol 3-benzoate results in increased expression of HELZ2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159
|
|
G |
Herc6 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HERC6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744
|
|
G |
Heyl |
hes-related family bHLH transcription factor with YRPW motif-like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HEYL mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:135,508,160...135,525,152
Ensembl chr 5:135,508,160...135,525,152
|
|
G |
Hip1 |
huntingtin interacting protein 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HIP1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:21,133,364...21,267,796
Ensembl chr12:21,133,406...21,267,725
|
|
G |
Hk3 |
hexokinase 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HK3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:9,596,950...9,614,847
Ensembl chr17:9,599,865...9,614,863
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HMOX1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hoxc5 |
homeo box C5 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of HOXC5 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 7:134,150,988...134,154,410
Ensembl chr 7:134,150,988...134,154,410
|
|
G |
Hrob |
homologous recombination factor with OB-fold |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HROB mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:87,206,017...87,222,483
Ensembl chr10:87,206,049...87,222,483
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HSD11B2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsh2d |
hematopoietic SH2 domain containing |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HSH2D mRNA |
CTD |
PMID:32741896 |
|
NCBI chr16:17,630,519...17,649,932
Ensembl chr16:17,635,322...17,647,991
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of HSPA2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
multiple interactions increases expression |
EXP |
[estradiol 3-benzoate co-treated with Progesterone] results in increased expression of HSPA8 mRNA; Progesterone promotes the reaction [estradiol 3-benzoate results in increased expression of HSPA8 mRNA] |
CTD |
PMID:9990085 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
multiple interactions increases expression |
EXP |
Raloxifene Hydrochloride inhibits the reaction [estradiol 3-benzoate results in increased expression of HTR2A mRNA]; Raloxifene Hydrochloride inhibits the reaction [estradiol 3-benzoate results in increased expression of HTR2A protein] estradiol 3-benzoate results in increased expression of HTR2A mRNA; estradiol 3-benzoate results in increased expression of HTR2A protein |
CTD |
PMID:17398000 |
|
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of HTR2C mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
|
|
G |
Hvcn1 |
hydrogen voltage-gated channel 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HVCN1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:34,341,673...34,370,010
Ensembl chr12:34,335,190...34,370,141
|
|
G |
Hyal3 |
hyaluronidase 3 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of HYAL3 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 8:108,254,385...108,260,020
Ensembl chr 8:108,250,667...108,260,647
|
|
G |
Icam2 |
intercellular adhesion molecule 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICAM2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293
|
|
G |
Icam5 |
intercellular adhesion molecule 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICAM5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:19,567,390...19,575,588
Ensembl chr 8:19,568,600...19,575,588
|
|
G |
Icos |
inducible T-cell co-stimulator |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICOS mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:62,368,075...62,406,900
Ensembl chr 9:62,383,832...62,405,672
|
|
G |
Ier5 |
immediate early response 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IER5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
|
|
G |
Ifi44 |
interferon-induced protein 44 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFI44 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
|
|
G |
Ifi44l |
interferon-induced protein 44-like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFI44L mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
|
|
G |
Ifit1bl |
interferon-induced protein with tetratricopeptide repeats 1B-like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFIT1BL mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:232,122,618...232,167,317
Ensembl chr 1:232,122,562...232,167,518
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFIT3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFITM1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Igf1 |
insulin-like growth factor 1 |
affects expression decreases expression |
EXP |
estradiol 3-benzoate affects the expression of IGF1 mRNA estradiol 3-benzoate results in decreased expression of IGF1 mRNA |
CTD |
PMID:15925091 PMID:19350480 PMID:21190954 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of IGFBP3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igh-6 |
immunoglobulin heavy chain 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGH-6 mRNA |
CTD |
PMID:32741896 |
|
|
|
G |
Igkv2-112l2 |
immunoglobulin kappa variable 2-112 like 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGKV2-112L2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:102,208,069...102,208,647
Ensembl chr 4:102,208,044...102,208,785
|
|
G |
Igkv28 |
immunoglobulin kappa chain variable 28 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGKV28 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:101,302,903...101,303,452
|
|
G |
Igkvl15 |
immunoglobulin kappa variable like 15 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGKVL15 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:3,093,174...3,093,807
Ensembl chr19:3,093,182...3,093,807
|
|
G |
Iglc1 |
immunoglobulin lambda constant 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGLL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:81,947,966...81,949,822
Ensembl chr11:81,947,934...81,949,822
|
|
G |
Igsf10 |
immunoglobulin superfamily, member 10 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGSF10 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:143,575,710...143,605,044
Ensembl chr 2:143,576,070...143,604,773
|
|
G |
Igsf6 |
immunoglobulin superfamily, member 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGSF6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:175,610,167...175,620,662
Ensembl chr 1:175,610,167...175,620,722
|
|
G |
Igsf7l1 |
immunoglobulin superfamily, member 7 like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGSF7L1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:100,174,955...100,182,713
Ensembl chr10:100,156,238...100,182,647
|
|
G |
Igsf9 |
immunoglobulin superfamily, member 9 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of IGSF9 promoter |
CTD |
PMID:27415467 |
|
NCBI chr13:84,948,643...84,965,616
Ensembl chr13:84,948,619...84,965,607
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IKZF1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL10 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL10RA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL1A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL1B mRNA; methyl palmitate inhibits the reaction [estradiol 3-benzoate results in increased expression of IL1B protein] |
CTD |
PMID:32741896 PMID:32967526 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL1R2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL1RN mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il21r |
interleukin 21 receptor |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL21R mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522
|
|
G |
Il27ra |
interleukin 27 receptor subunit alpha |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL27RA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL2RA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il36b |
interleukin 36, beta |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL36B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:7,024,881...7,030,388
Ensembl chr 3:7,021,973...7,031,619
|
|
G |
Il7r |
interleukin 7 receptor |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL7R mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Inhbb |
inhibin subunit beta B |
decreases expression multiple interactions |
EXP |
estradiol 3-benzoate results in decreased expression of INHBB mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of INHBB mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
|
|
G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of INPP5D mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
|
|
G |
Ip6k1 |
inositol hexakisphosphate kinase 1 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of IP6K1 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 8:108,693,068...108,737,278
|
|
G |
Irag2 |
inositol 1,4,5-triphosphate receptor associated 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRAG2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:178,088,902...178,143,569
Ensembl chr 4:178,088,507...178,143,557
|
|
G |
Irak1bp1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRAK3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Irf4 |
interferon regulatory factor 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRF4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
|
|
G |
Irf7 |
interferon regulatory factor 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRF7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irgm |
immunity-related GTPase M |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRGM mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ISG15 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Itga4 |
integrin subunit alpha 4 |
increases expression multiple interactions |
EXP |
estradiol 3-benzoate results in increased expression of ITGA4 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGA4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
|
|
G |
Itga8 |
integrin subunit alpha 8 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGA8 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:75,304,004...75,501,510
Ensembl chr17:75,304,008...75,501,510
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGAM mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgax |
integrin subunit alpha X |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGAX mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
|
|
G |
Itgb2 |
integrin subunit beta 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGB2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Itgb7 |
integrin subunit beta 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGB7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:133,347,927...133,364,955
Ensembl chr 7:133,347,960...133,364,876
|
|
G |
Izumo1r |
IZUMO1 receptor, JUNO |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IZUMO1R mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:11,744,384...11,748,131
Ensembl chr 8:11,725,863...11,748,465
|
|
G |
Jchain |
joining chain of multimeric IgA and IgM |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of JCHAIN mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:19,538,927...19,547,023
Ensembl chr14:19,538,952...19,546,298
|
|
G |
Jph3 |
junctophilin 3 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of JPH3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:49,793,967...49,855,338
Ensembl chr19:49,793,092...49,855,338
|
|
G |
Katnal2 |
katanin catalytic subunit A1 like 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of KATNAL2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:70,531,759...70,607,886
Ensembl chr18:70,531,754...70,608,082
|
|
G |
Katnb1 |
katanin regulatory subunit B1 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of KATNB1 promoter |
CTD |
PMID:27415467 |
|
NCBI chr19:9,921,216...9,940,853
Ensembl chr19:9,921,219...9,940,650
|
|
G |
Kcnd1 |
potassium voltage-gated channel subfamily D member 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KCND1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr X:14,661,688...14,678,745
Ensembl chr X:14,662,357...14,677,233
|
|
G |
Kcnk2 |
potassium two pore domain channel subfamily K member 2 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of KCNK2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
|
|
G |
Kcnk7 |
potassium two pore domain channel subfamily K member 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KCNK7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:202,988,801...202,992,842
Ensembl chr 1:202,990,198...202,992,872
|
|
G |
Kcnq1 |
potassium voltage-gated channel subfamily Q member 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KCNQ1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669
|
|
G |
Kcnt1 |
potassium sodium-activated channel subfamily T member 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KCNT1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:8,682,964...8,736,615
Ensembl chr 3:8,682,113...8,736,667
|
|
G |
Kif18b |
kinesin family member 18B |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KIF18B mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:87,870,424...87,889,895
Ensembl chr10:87,870,428...87,889,850
|
|
G |
Kif20a |
kinesin family member 20A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KIF20A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
|
|
G |
Kif6 |
kinesin family member 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of KIF6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:11,076,203...11,373,205
Ensembl chr 9:11,072,824...11,373,006
|
|
G |
Kiss1 |
KiSS-1 metastasis-suppressor |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of KISS1 mRNA; estradiol 3-benzoate results in decreased expression of KISS1 protein |
CTD |
PMID:19106226 PMID:19442818 PMID:20951797 PMID:21190954 PMID:22016562 |
|
NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612
|
|
G |
Kiss1r |
KISS1 receptor |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of KISS1R mRNA |
CTD |
PMID:21277884 |
|
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
|
|
G |
Klhl12 |
kelch-like family member 12 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of KLHL12 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:45,899,913...45,933,648
Ensembl chr13:45,899,928...45,933,643
|
|
G |
Klhl3 |
kelch-like family member 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLHL3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:6,523,089...6,645,971
Ensembl chr17:6,521,912...6,642,154
|
|
G |
Klhl6 |
kelch-like family member 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLHL6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:80,970,917...81,010,593
Ensembl chr11:80,970,917...81,009,677
|
|
G |
Klrc1 |
killer cell lectin like receptor C1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLRC1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:163,142,142...163,152,425
Ensembl chr 4:163,147,189...163,152,425
|
|
G |
Klrc2 |
killer cell lectin like receptor C2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLRC2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:163,122,700...163,133,843
Ensembl chr 4:163,122,704...163,133,843
|
|
G |
Klrc3 |
killer cell lectin like receptor C3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLRC3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:163,105,081...163,112,737
Ensembl chr 4:163,106,024...163,112,336
|
|
G |
Klrd1 |
killer cell lectin like receptor D1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLRD1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:163,044,920...163,056,568
Ensembl chr 4:163,045,067...163,056,518
|
|
G |
Kmo |
kynurenine 3-monooxygenase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KMO mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
|
|
G |
Kng1 |
kininogen 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNG1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Kng2l1 |
kininogen 2-like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNG2L1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:77,978,795...78,002,976
Ensembl chr11:77,909,612...78,002,971
|
|
G |
Knl1 |
kinetochore scaffold 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
|
|
G |
Knstrn |
kinetochore-localized astrin/SPAG5 binding protein |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNSTRN mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
|
|
G |
Krt20 |
keratin 20 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT20 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107
|
|
G |
Krt25 |
keratin 25 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of KRT25 promoter |
CTD |
PMID:27415467 |
|
NCBI chr10:84,267,399...84,275,025
Ensembl chr10:84,267,399...84,274,965
|
|
G |
Krt36 |
keratin 36 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT36 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:85,036,379...85,040,003
Ensembl chr10:85,036,594...85,039,959
|
|
G |
Krt7 |
keratin 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
|
|
G |
Krt8 |
keratin 8 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of KRT8 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Krt87 |
keratin 87 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of KRT83 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 7:132,547,388...132,555,005
Ensembl chr 7:132,548,141...132,554,978
|
|
G |
Krtap16-5 |
keratin associated protein 16-5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRTAP16-5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:28,249,212...28,249,796
Ensembl chr11:28,249,212...28,249,796
|
|
G |
Lacc1 |
laccase domain containing 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LACC1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:52,390,267...52,407,630
Ensembl chr15:52,395,183...52,407,545
|
|
G |
Lag3 |
lymphocyte activating 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAG3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:157,712,665...157,722,229
Ensembl chr 4:157,712,667...157,720,404
|
|
G |
Lamb1 |
laminin subunit beta 1 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of LAMB1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
|
|
G |
Laptm5 |
lysosomal protein transmembrane 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAPTM5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
|
|
G |
Lat2 |
linker for activation of T cells family, member 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAT2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:22,104,173...22,118,294
Ensembl chr12:22,104,219...22,118,288
|
|
G |
Lbp |
lipopolysaccharide binding protein |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LBP mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LCN2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lcp2 |
lymphocyte cytosolic protein 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LCP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:18,642,600...18,689,562
Ensembl chr10:18,642,658...18,689,559
|
|
G |
Ldlrad2 |
low density lipoprotein receptor class A domain containing 2 |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of LDLRAD2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:149,778,795...149,788,335
Ensembl chr 5:149,779,675...149,787,140
|
|
G |
Lepr |
leptin receptor |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of LEPR mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lgals3bp |
galectin 3 binding protein |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGALS3BP mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
|
|
G |
Lgals9 |
galectin 9 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGALS9 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
|
|
G |
Lgi2 |
leucine-rich repeat LGI family, member 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGI2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:58,415,965...58,443,450
Ensembl chr14:58,415,965...58,443,407
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases expression multiple interactions increases secretion decreases secretion |
ISO EXP |
estradiol 3-benzoate results in decreased expression of LHB mRNA [estradiol 3-benzoate co-treated with Progesterone] results in increased abundance of LHB protein estradiol 3-benzoate results in increased secretion of LHB protein Atrazine inhibits the reaction [[estradiol 3-benzoate co-treated with Progesterone] results in increased secretion of LHB protein]; Atrazine inhibits the reaction [estradiol 3-benzoate results in increased secretion of LHB protein]; Quercetin inhibits the reaction [estradiol 3-benzoate results in decreased secretion of LHB protein]; Raloxifene Hydrochloride inhibits the reaction [estradiol 3-benzoate results in increased secretion of LHB protein] |
CTD |
PMID:10696778 PMID:15056801 PMID:15223135 PMID:16614383 PMID:17398000 PMID:22577852 PMID:24316378 More...
|
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
increases expression |
ISO |
estradiol 3-benzoate results in increased expression of LHCGR mRNA |
CTD |
PMID:15223135 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lhx8 |
LIM homeobox 8 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LHX8 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:243,244,958...243,269,624
Ensembl chr 2:243,244,961...243,269,416
|
|
G |
Lilra5 |
leukocyte immunoglobulin like receptor A5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LILRA5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:69,973,292...69,978,750
Ensembl chr 1:69,973,292...70,001,718
|
|
G |
Lilrb4 |
leukocyte immunoglobulin like receptor B4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LILRB4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:69,805,020...69,810,628
Ensembl chr 1:69,805,250...69,810,660
|
|
G |
Lilrc2 |
leukocyte immunoglobulin-like receptor, subfamily C, member 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LILRC2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:65,272,134...65,277,278
Ensembl chr 1:65,272,796...65,277,271
|
|
G |
Lin7a |
lin-7 homolog A, crumbs cell polarity complex component |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of LIN7A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
|
|
G |
Lipg |
lipase G, endothelial type |
decreases expression |
EXP |
estradiol 3-benzoate results in decreased expression of LIPG mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
G |
Lix1 |
limb and CNS expressed 1 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of LIX1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:58,128,961...58,187,554
Ensembl chr 1:58,128,961...58,185,964
|
|
G |
Loxl1 |
lysyl oxidase-like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LOXL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
|
|
G |
Lrcol1 |
leucine rich colipase-like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of LRCOL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:46,326,049...46,339,475
Ensembl chr12:46,326,077...46,337,953
|
|
G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRG1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
|
|
G |
Lrrc1 |
leucine rich repeat containing 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of LRRC1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:78,239,897...78,407,347
Ensembl chr 8:78,239,900...78,406,490
|
|
G |
Lrrc15 |
leucine rich repeat containing 15 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of LRRC15 promoter |
CTD |
PMID:27415467 |
|
NCBI chr11:70,469,817...70,484,268
Ensembl chr11:70,469,804...70,484,267
|
|
G |
Lrrc17 |
leucine rich repeat containing 17 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRC17 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:13,501,428...13,531,845
Ensembl chr 4:13,501,436...13,531,845
|
|
G |
Lrrc18 |
leucine rich repeat containing 18 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of LRRC18 promoter |
CTD |
PMID:27415467 |
|
NCBI chr16:8,253,524...8,277,141
Ensembl chr16:8,254,352...8,277,437
|
|
G |
Lrrc4 |
leucine rich repeat containing 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRC4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:57,433,518...57,437,114
Ensembl chr 4:57,433,428...57,437,911
|
|
G |
Lrrc73 |
leucine rich repeat containing 73 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of LRRC73 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:14,726,157...14,730,144
Ensembl chr 9:14,726,158...14,729,158
|
|
G |
Lrrc74a |
leucine rich repeat containing 74A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRC74A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:106,386,276...106,417,112
Ensembl chr 6:106,386,347...106,416,193
|
|
G |
Lrrn4cl |
LRRN4 C-terminal like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRN4CL mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:205,743,580...205,759,879
|
|
G |
LRRTM1 |
leucine rich repeat transmembrane neuronal 1 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of LRRTM1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:109,701,815...109,718,924
Ensembl chr 4:109,701,815...109,717,184
|
|
G |
Lsp1 |
lymphocyte-specific protein 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LSP1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:197,614,677...197,648,414
Ensembl chr 1:197,614,687...197,648,416
|
|
G |
Lst1 |
leukocyte specific transcript 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LST1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr20:3,634,680...3,639,731
Ensembl chr20:3,634,749...3,637,997
|
|
G |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of LTBP2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
|
|
G |
Ltk |
leukocyte receptor tyrosine kinase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LTK mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:106,734,675...106,741,552
Ensembl chr 3:106,734,676...106,743,369
|
|
G |
Ly49i7 |
Ly49 inhibitory receptor 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49I7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:164,853,287...164,871,902
Ensembl chr 4:164,853,574...164,867,333
|
|
G |
Ly49i9 |
Ly49 inhibitory receptor 9 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49I9 mRNA |
CTD |
PMID:32741896 |
|
|
|
G |
Ly49s3 |
Ly-49 stimulatory receptor 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49S3 mRNA |
CTD |
PMID:32741896 |
|
Ensembl chr 4:164,122,072...164,341,692
|
|
G |
Ly49s6 |
Ly49 stimulatory receptor 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49S6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:164,080,442...164,104,904
Ensembl chr 4:163,884,837...164,104,899 Ensembl chr 4:163,884,837...164,104,899
|
|
G |
Ly49si1 |
immunoreceptor Ly49si1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49SI1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:163,586,930...163,600,528
Ensembl chr 4:163,514,541...163,751,214
|
|
G |
Ly49si2 |
immunoreceptor Ly49si2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49SI2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:163,672,025...163,845,961
Ensembl chr 4:163,514,541...163,751,214
|
|
G |
Ly6a |
lymphocyte antigen 6 family member A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6AL mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981
|
|
G |
Ly6c |
Ly6-C antigen |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6C mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:106,959,508...106,963,329
Ensembl chr 7:106,959,511...106,963,329
|
|
G |
Ly6cl1 |
Ly6-C antigen like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6CL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:107,122,197...107,163,755
Ensembl chr 7:107,011,588...107,163,788
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6E mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
|
|
G |
Ly6l |
lymphocyte antigen 6 family member L |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6L mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:107,220,612...107,222,692
Ensembl chr 7:107,141,903...107,143,843
|
|
G |
Ly86 |
lymphocyte antigen 86 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY86 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:27,415,807...27,499,695
Ensembl chr17:27,415,830...27,487,260
|
|
G |
Lyl1 |
LYL1, basic helix-loop-helix family member |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:23,452,140...23,455,007
Ensembl chr19:23,452,140...23,455,007
|
|
G |
Lynx1 |
Ly6/neurotoxin 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYNX1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:106,632,800...106,638,003
Ensembl chr 7:106,632,797...106,638,023
|
|
G |
Lypd8 |
Ly6/Plaur domain containing 8 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYPD8 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:42,561,834...42,572,684
Ensembl chr10:42,561,816...42,572,683
|
|
G |
Lyz2 |
lysozyme 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYZ2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
|
|
G |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MACROD2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:127,720,066...129,737,511
Ensembl chr 3:127,720,181...129,734,492
|
|
G |
Maf |
MAF bZIP transcription factor |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MAF mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
|
|
G |
Mall |
mal, T-cell differentiation protein-like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MALL mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785
|
|
G |
Man1c1 |
mannosidase, alpha, class 1C, member 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MAN1C1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:146,774,282...146,913,257
Ensembl chr 5:146,775,842...146,913,421
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
decreases phosphorylation |
EXP |
estradiol 3-benzoate results in decreased phosphorylation of MAP2K1 protein |
CTD |
PMID:15778002 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
decreases phosphorylation |
EXP |
estradiol 3-benzoate results in decreased phosphorylation of MAP2K2 protein |
CTD |
PMID:15778002 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
EXP |
estradiol 3-benzoate results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:15778002 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
EXP |
estradiol 3-benzoate results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:15778002 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Marchf10 |
membrane associated ring-CH-type finger 10 |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of MARCHF10 promoter |
CTD |
PMID:27415467 |
|
NCBI chr10:90,332,783...90,423,109
Ensembl chr10:90,332,784...90,421,588
|
|
G |
Marcksl1 |
MARCKS-like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MARCKSL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
|
|
G |
Mcemp1 |
mast cell-expressed membrane protein 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MCEMP1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:1,721,781...1,727,350
Ensembl chr12:1,718,730...1,725,986
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MCM3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mcoln2 |
mucolipin TRP cation channel 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MCOLN2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:235,053,816...235,102,703
Ensembl chr 2:235,053,816...235,102,702
|
|
G |
Mcoln3 |
mucolipin TRP cation channel 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MCOLN3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:235,008,716...235,042,885
Ensembl chr 2:234,966,010...235,043,047
|
|
G |
Mfap2 |
microfibril associated protein 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MFAP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:153,312,068...153,320,266
Ensembl chr 5:153,314,711...153,320,259
|
|
G |
Mgam |
maltase-glucoamylase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MGAM mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:69,441,626...69,602,068
Ensembl chr 4:69,446,150...69,692,715
|
|
G |
Milr1 |
mast cell immunoglobulin-like receptor 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MILR1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:91,684,288...91,705,284
Ensembl chr10:91,687,831...91,705,282
|
|
G |
Mir615 |
microRNA 615 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of MIR615 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 7:134,151,887...134,151,978
Ensembl chr 7:134,151,887...134,151,978
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MKI67 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp16 |
matrix metallopeptidase 16 |
increases expression |
EXP |
estradiol 3-benzoate results in increased expression of MMP16 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:31,312,280...31,556,276
Ensembl chr 5:31,312,280...31,548,388
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MMP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp28 |
matrix metallopeptidase 28 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MMP28 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:68,241,138...68,264,866
Ensembl chr10:68,241,138...68,264,866
|
|
G |
Mmp8 |
matrix metallopeptidase 8 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MMP8 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
|
|
G |
Mnda |
myeloid cell nuclear differentiation antigen |
multiple interactions increases expression |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MNDA mRNA estradiol 3-benzoate results in increased expression of MNDA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
|
|
G |
Mpeg1 |
macrophage expressed 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MPEG1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:209,452,176...209,456,692
Ensembl chr 1:209,452,133...209,458,855
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [estradiol 3-benzoate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MPO protein]]; estradiol 3-benzoate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MPO protein] |
CTD |
PMID:27363640 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mpz |
myelin protein zero |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MPZ mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:83,570,811...83,576,680
Ensembl chr13:83,570,811...83,576,679
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MRC1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Mrgprx3 |
MAS related GPR family member X3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MRGPRX3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:97,720,377...97,746,953
Ensembl chr 1:97,721,436...97,746,900
|
|
G |
Ms4a1 |
membrane spanning 4-domains A1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512
|
|
G |
Ms4a10 |
membrane spanning 4-domains A10 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A10 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:207,611,312...207,624,452
Ensembl chr 1:207,611,312...207,624,452
|
|
G |
Ms4a12 |
membrane spanning 4-domains A12 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A12 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:207,881,065...207,894,633
Ensembl chr 1:207,882,333...207,893,938
|
|
G |
Ms4a18 |
membrane spanning 4-domains A18 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A18 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:207,644,858...207,662,471
Ensembl chr 1:207,645,780...207,665,793
|
|
G |
Ms4a4a |
membrane spanning 4-domains A4A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A4E mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:208,060,507...208,085,121
Ensembl chr 1:208,046,971...208,085,119
|
|
G |
Ms4a6a |
membrane spanning 4-domains A6A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:208,401,465...208,414,831
Ensembl chr 1:208,401,466...208,414,758
|
|
G |
Ms4a6bl1 |
membrane-spanning 4-domains, subfamily A, member 6B-like 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6BL1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:208,243,561...208,255,400
Ensembl chr 1:208,243,559...208,257,340
|
|
G |
Ms4a6c |
membrane-spanning 4-domains, subfamily A, member 6C |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6E mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:208,153,504...208,174,721
Ensembl chr 1:208,153,530...208,174,479
|
|
G |
Ms4a7 |
membrane spanning 4-domains A7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260
|
|
G |
Msc |
musculin |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MSC mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 5:4,547,335...4,553,206
Ensembl chr 5:4,547,405...4,553,203
|
|
G |
Msln |
mesothelin |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MSLN mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
|
|
G |
Mstn |
myostatin |
multiple interactions decreases expression |
EXP |
estradiol 3-benzoate promotes the reaction [Progesterone results in decreased expression of MSTN mRNA] estradiol 3-benzoate results in decreased expression of MSTN mRNA |
CTD |
PMID:18845635 |
|
NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:48,452,533...48,458,933
|
|
G |
Mt3 |
metallothionein 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MT3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Mt4 |
metallothionein 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MT4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:10,863,813...10,865,909
Ensembl chr19:10,863,813...10,865,909
|
|
G |
Mthfd2l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MTHFD2L mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:17,089,947...17,170,036
Ensembl chr14:17,089,952...17,170,112
|
|
G |
Mx1 |
MX dynamin like GTPase 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MX1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MYCN mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
|
|
G |
Myh9 |
myosin, heavy chain 9 |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of MYH9 promoter |
CTD |
PMID:27415467 |
|
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
|
|
G |
Mylk3 |
myosin light chain kinase 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MYLK3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:21,685,085...21,743,587
Ensembl chr19:21,691,929...21,742,954
|
|
G |
Myo1f |
myosin IF |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MYO1F mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:14,363,340...14,413,911
Ensembl chr 7:14,363,350...14,413,911
|
|
G |
Myo7a |
myosin VIIA |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MYO7A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:152,342,611...152,414,171
Ensembl chr 1:152,344,448...152,414,157
|
|
G |
Mzb1 |
marginal zone B and B1 cell-specific protein |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MZB1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr18:27,238,999...27,241,060
Ensembl chr18:27,239,001...27,241,094
|
|
G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of N4BP2L2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
|
|
G |
Naaa |
N-acylethanolamine acid amidase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAAA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr14:15,777,306...15,796,411
Ensembl chr14:15,777,306...15,796,410
|
|
G |
Napepld |
N-acyl phosphatidylethanolamine phospholipase D |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAPEPLD mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 4:13,360,532...13,398,815
Ensembl chr 4:13,361,006...13,398,748
|
|
G |
Napsa |
napsin A aspartic peptidase |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAPSA mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:95,064,726...95,077,101
Ensembl chr 1:95,064,900...95,077,094
|
|
G |
Nav3 |
neuron navigator 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAV3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:45,052,206...45,840,471
Ensembl chr 7:45,054,296...45,840,698
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NCAM1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NCF1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Ncf4 |
neutrophil cytosolic factor 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NCF4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:109,825,420...109,843,389
Ensembl chr 7:109,826,020...109,843,389
|
|
G |
Nckap1l |
NCK associated protein 1 like |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NCKAP1L mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:134,577,470...134,622,928
Ensembl chr 7:134,577,482...134,622,934
|
|
G |
Ndc80 |
NDC80 kinetochore complex component |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NDC80 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
|
|
G |
Ndfip2 |
Nedd4 family interacting protein 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NDFIP2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr15:82,032,366...82,087,043
Ensembl chr15:82,032,366...82,086,317
|
|
G |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of NECAB2 promoter |
CTD |
PMID:27415467 |
|
NCBI chr19:47,501,351...47,527,722
Ensembl chr19:47,501,302...47,527,684
|
|
G |
Nek6 |
NIMA-related kinase 6 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NEK6 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990
|
|
G |
Nell2 |
neural EGFL like 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NELL2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:126,343,089...126,662,903
Ensembl chr 7:126,198,851...126,733,503
|
|
G |
Neurl3 |
neuralized E3 ubiquitin protein ligase 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NEURL3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 9:38,494,486...38,503,352
Ensembl chr 9:38,494,489...38,502,649
|
|
G |
Nfam1 |
NFAT activating protein with ITAM motif 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NFAM1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:114,139,318...114,175,395
Ensembl chr 7:114,139,345...114,175,442
|
|
G |
Nfe2 |
nuclear factor, erythroid 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NFE2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
|
|
G |
Nfia |
nuclear factor I/A |
increases methylation |
EXP |
estradiol 3-benzoate results in increased methylation of NFIA promoter |
CTD |
PMID:27415467 |
|
NCBI chr 5:112,436,655...112,781,878
Ensembl chr 5:112,436,644...112,775,885
|
|
G |
Nfkbid |
NFKB inhibitor delta |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NFKBID mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:85,679,353...85,690,415
Ensembl chr 1:85,680,861...85,690,447
|
|
G |
Nkain3 |
Sodium/potassium transporting ATPase interacting 3 |
decreases methylation |
EXP |
estradiol 3-benzoate results in decreased methylation of NKAIN3 gene |
CTD |
PMID:35026373 |
|
NCBI chr 5:33,613,720...34,310,090
Ensembl chr 5:33,623,713...34,309,381
|
|
G |
Nkd1 |
NKD inhibitor of WNT signaling pathway 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NKD1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380
|
|
G |
Nkg7 |
natural killer cell granule protein 7 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NKG7 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:93,844,748...93,845,975
Ensembl chr 1:93,844,902...93,845,983
|
|
G |
Nkx1-2 |
NK1 homeobox 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NKX1-2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:187,386,370...187,391,252
Ensembl chr 1:187,388,711...187,391,149
|
|
G |
Nlrc3 |
NLR family, CARD domain containing 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRC3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:11,551,378...11,585,027
Ensembl chr10:11,551,356...11,584,398
|
|
G |
Nlrc5 |
NLR family, CARD domain containing 5 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRC5 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr19:10,477,638...10,581,023
Ensembl chr19:10,477,628...10,562,121
|
|
G |
Nlrp12 |
NLR family, pyrin domain containing 12 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRP12 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:65,932,610...65,969,873
Ensembl chr 1:65,932,595...65,960,934
|
|
G |
Nlrp1a |
NLR family, pyrin domain containing 1A |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRP1A mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:55,778,560...55,833,639
Ensembl chr10:55,778,560...55,825,180
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRP3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nol10 |
nucleolar protein 10 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NOL10 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 6:40,144,217...40,225,353
Ensembl chr 6:40,144,235...40,225,353
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
EXP |
[Progesterone co-treated with estradiol 3-benzoate] results in increased expression of NOS1 protein |
CTD |
PMID:15347845 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NOX4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Noxo1 |
NADPH oxidase organizer 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NOXO1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr10:13,723,253...13,726,008
Ensembl chr10:13,721,473...13,726,061
|
|
G |
Np4 |
defensin NP-4 precursor |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NP4 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr16:70,494,607...70,497,261
Ensembl chr16:70,342,529...70,497,202
|
|
G |
Npr1 |
natriuretic peptide receptor 1 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NPR1 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:175,934,181...175,949,505
|
|
G |
Npy4r |
neuropeptide Y receptor Y4 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NPY4R mRNA |
CTD |
PMID:32741896 |
|
NCBI chr16:9,467,801...9,469,057
Ensembl chr16:9,467,801...9,469,057
|
|
G |
Nr2e3 |
nuclear receptor subfamily 2, group E, member 3 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NR2E3 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr 8:60,365,581...60,373,383
Ensembl chr 8:60,366,124...60,373,163
|
|
G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
multiple interactions |
EXP |
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NR5A2 mRNA |
CTD |
PMID:32741896 |
|
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
|
|
G |
Nrgn |
neurogranin |
multiple interactions | |